정규장
Log in Sign up
SNYR
SNYR
Synergy CHC Corp
7월 28일 12:57 PM ET (한국 7/29 01:57)
$0.17
+0.00 -1.52%

시너지 CHC(SNYR) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$3M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 +3% · 고점 -96%
애널리스트
적극 매수
F
Fundamental health
vs. 방어주 초소형주· based on 3 axes
수익성 ⓘ
산출 불가 (적자)
성장 ⓘ
Top 33%
밸류에이션 ⓘ
Top 100%
재무 안정 ⓘ
Top 86%
💰 Is this stock pricier than usual right now? ⓘ
Compared to this company's own recent 1년 (not other companies).
Very cheap
Cheap
Typical
Pricey
Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 8원. Over the past 1년, it usually traded around 9원. On the cheaper side versus its own history.
Pricy doesn't mean bad — it means expectations are already baked in.· based on 1.2 profitable years
Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -1.36Insider Own ⓘ 42.99%Shs Outstand ⓘ 11.3MPerf Week ⓘ -9.34%
Market Cap ⓘ 0.00BForward P/E ⓘ 1.12EPS next Y ⓘ 178.95%Insider Trans ⓘ -Shs Float ⓘ 8.5MPerf Month ⓘ -17.29%
Enterprise Value ⓘ 0.03BPEG ⓘ -EPS next Q ⓘ -0.01Inst Own ⓘ 10.11%Short Float ⓘ 0.93%Perf Quarter ⓘ -57.98%
Income ⓘ -0.02BP/S ⓘ 0.09EPS this Y ⓘ 85.04%Inst Trans ⓘ -5.58%Short Ratio ⓘ 0.03Perf Half Y ⓘ -90.97%
Sales ⓘ 0.03BP/B ⓘ -EPS next 5Y ⓘ -ROA ⓘ -142.75%Short Interest ⓘ 0.08MPerf YTD ⓘ -90.97%
Book/sh ⓘ -2.25P/C ⓘ 6.41EPS past 3/5Y ⓘ 69.66% 37.04%ROE ⓘ -52W High ⓘ -95.79% ($3.99)Perf Year ⓘ -95.57%
Cash/sh ⓘ 0.03P/FCF ⓘ -Sales past 3/5Y ⓘ -7.52% 0.69%ROIC ⓘ -52W Low ⓘ 3.32% ($0.16)Perf 3Y ⓘ 41.09%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -221.57%Gross Margin ⓘ 64.89%Volatility(W/M) ⓘ 5.5% 5.06%Perf 5Y ⓘ -71.84%
Dividend TTM ⓘ -EV/Sales ⓘ 1.08Sales Y/Y TTM ⓘ -17.53%Oper. Margin ⓘ -39.61%ATR (14) ⓘ 0.01Perf 10Y ⓘ -96.47%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.43EPS Q/Q ⓘ -322.41%Profit Margin ⓘ -56.98%RSI (14) ⓘ 31.25Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.93Sales Q/Q ⓘ -32.77%SMA20 ⓘ -12.94% ($0.2)Beta ⓘ -1.4Target Price ⓘ $3.75
Payout ⓘ -Debt/Eq ⓘ -Earnings ⓘ 2026/5/14SMA50 ⓘ -22.83% ($0.22)Rel Volume ⓘ 0.04Prev Close ⓘ $0.17
Employees ⓘ 28LT Debt/Eq ⓘ -EPS/Sales Surpr. ⓘ -866.67% -34.09%SMA200 ⓘ -86.34% ($1.24)Avg Volume(3M) ⓘ 2.57MPrice ⓘ $0.17
IPO ⓘ 2014/3/17Option/Short ⓘ No/YesTrades ⓘ 147Volume ⓘ 97,622Change ⓘ -1.52%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $5M (YoY -33%) · 순이익 $-3M (YoY -393%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Synergy CHC Corp (SNYR) Investment Analysis

What kind of company is Synergy CHC Corp?

시너지 CHC(SNYR) 방어주
Healthcare · Medical Distribution
Small-Cap — Low Volume, High Volatility

🧠 Synergy CHC () is a small-cap consumer healthcare company that sells brain health supplements (FOCUSfactor) and lifestyle brand products (Flat Tummy) at the center of its consumer health and beauty lineup. It leverages both online channels and offline distribution, and is a micro-cap stock currently building growth momentum through the recent expansion of its functional beverage (FOCUSfactor Beverage) line.

Learn more about Synergy CHC Corp →
Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5785
Employees28people
IPO2014/03/17
Current Price$0.17 ≈ 233원
NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 5월 14일 (목) · 장 시작 전 EPS -866.7% 매출 -34.1%
🔔 Earnings release 2026년 4월 1일 (수) · 장 시작 전 EPS -13600.0% 매출 -44.0%

Is it profitable?

Both profitability & finances need caution
Review management risk carefully before investing
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
-39.6%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Net Margin
Share of revenue left after taxes and interest are paid
-57.0%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
64.9%
✓ 양호
My positionMid-range
Low range Average High range
Healthcare 초소형주 Median 42.6% · Top 30%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROA
Annual earnings relative to total company assets
-142.8%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Financial health — Debt & liquidity burden
Current Ratio
Liquid assets available to cover liabilities due within a year
0.93
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 초소형주 Median 2.76
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.43
✓ 부진
My positionBottom 25%
Low range Average High range
Healthcare 초소형주 Median 2.54
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook
Price targets, growth, and valuation are favorable
애널리스트 목표가
$3.75
현재가 대비 +2105.9%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
1.12배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
내년 EPS 예상 성장률
+178.9%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Volatility
Frequently misses analyst estimates
0
예상 상회
0
예상 부합
2
예상 하회
0%
상회 비율
-2215.3%
평균 서프라이즈
2026.05.14
하회
실적 $-0.22 · 예상 $0.03 -848.7%
2026.04.01
하회
실적 $-0.35 · 예상 $0.01 -3582.0%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Strong Growth
Above the industry average, both historically and going forward
Margin-Driven Growth EPS is growing while revenue is flat — gains may come from cost cuts, so watch sustainability
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+85.0%
우수
My positionTop 25%
Low range Average High range
방어주 초소형주 Median 21.2% · Top 15%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+178.9%
우수
My positionTop 25%
Low range Average High range
방어주 초소형주 Median 14.5% · Top 7%
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+69.7%
우수
My positionTop 25%
Low range Average High range
방어주 초소형주 Median 30.0% · Top 20%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+37.0%
양호
My positionMid-range
Low range Average High range
방어주 초소형주 Median 16.4% · Top 32%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+0.7%
평균
My positionMid-range
Low range Average High range
방어주 초소형주 Median 2.1% · Bottom 47%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
-32.8%
평균
My positionMid-range
Low range Average High range
방어주 초소형주 Median -4.5% · Bottom 26%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -140%p below the market
SNYR -71.8% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-140.2%p
Significantly behind the market
vs Health Care (XLV)
-96.3%p
Significantly behind the sector average
1-year basis
vs S&P 500
-111.6%p
Significantly behind the market
vs Health Care (XLV)
-115.3%p
Significantly behind the sector average
Current position within 52-week range
Low (-3.3%p) High (-95.8%p)
Current price is 3.3% above the 52-week low and 95.8% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-90.5%
Annualized volatility
96.6%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $0.17 below the midline ($0.19). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡
Current diagnosis · 2026-07-27
Neutral zone — weak trend

MACD -0.017 · Signal -0.018 · Hist 0.000. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 31.1 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 20.0.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Earnings·Vs. Sales
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Cheap
🧾 Vs. Sales Cheap
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
1.12x
✓ Very cheap
My positionTop 5%
Low range Average High range
Healthcare 초소형주 median 11.43x · Top 1% — relatively cheap within the industry
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
0.09x
✓ Very cheap
My positionTop 5%
Low range Average High range
Healthcare 초소형주 median 3.22x · Top 1% — relatively cheap within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
Analyst target price (reference)
$3.75 vs. current price +2105.9%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Healthcare 초소형주

Who owns it?

Ownership flow shows some pressure
Institutional net selling -5.6% · Short interest light 0.9%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-5.6%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 10.1%
Retail-led
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 43.0%
Founder/management large holders (strong skin-in-the-game)
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 46.9%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
0.9%
Low — limited short-side pressure
Healthcare 초소형주 Median 3.9%
Past 90 days Little change
Short interest days to cover
0.0 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 11.3M주
Float (tradable shares) 8.5M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
SNYR SNYR This Stock
$2.5M- - - - -1.5%
LLY
$1.13T43.1 ▼36.2 ▼107.64% ▲0.58% ▼+0.1%
JNJ
$640.9B30.8 ▼7.5 ▼25.74% ▲2.02% ▲+1.0%
ABBV
$453.9B126.7 ▼- 15221.82% ▲2.67% ▲-0.9%
UNH
$379.3B26.9 ▼3.9 ▼12.49% ▲2.16% ▲-0.7%
MRK
$323.0B36.8 ▼7.0 ▼18.97% ▲2.5% ▲-0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
시너지 CHC(SNYR) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
$SNYR는 두뇌 건강 보충제 FOCUSfactor와 라이프스타일 브랜드 Flat Tummy를 보유한 마이크로캡 컨슈머 헬스케어 기업입니다.
📚 Related Investment Guides
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 시너지 CHC(SNYR)?

시너지 CHC(SNYR) belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is the market cap of SNYR?

The market cap of SNYR is approximately $3M, ranking 5,785 within its sector.

What is the 52-week high and low for SNYR?

SNYR has recorded a 52-week high of $3.99 and a low of $0.16.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.